相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Blood amyloid- oligomerization associated with neurodegeneration of Alzheimer's disease
Young Chul Youn et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Amyloid β oligomers (AβOs) in Alzheimer's disease
Barbara Mroczko et al.
JOURNAL OF NEURAL TRANSMISSION (2018)
Sulforaphane Inhibits the Generation of Amyloid-β Oligomer and Promotes Spatial Learning and Memory in Alzheimer's Disease (PS1V97L) Transgenic Mice
Ting-Ting Hou et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
Melanie D. Sweeney et al.
NATURE REVIEWS NEUROLOGY (2018)
The effect of amyloid-β peptide on synaptic plasticity and memory is influenced by different isoforms, concentrations, and aggregation status
Walter Gulisano et al.
NEUROBIOLOGY OF AGING (2018)
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
Giovanni B. Frisoni et al.
LANCET NEUROLOGY (2017)
Clinical validity of delayed recall tests as a gateway biomarker for Alzheimer's disease in the context of a structured 5-phase development framework
Chiara Cerami et al.
NEUROBIOLOGY OF AGING (2017)
Dynamic changes of oligomeric amyloid β levels in plasma induced by spiked synthetic Aβ42
Seong Soo A. An et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer's disease
Min Jeong Wang et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Free and Cued Selective Reminding Test - accuracy for the differential diagnosis of Alzheimer's and neurodegenerative diseases: A large-scale biomarker-characterized monocenter cohort study (ClinAD)
Marc Teichmann et al.
ALZHEIMERS & DEMENTIA (2017)
Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis
Kirsten L. Viola et al.
ACTA NEUROPATHOLOGICA (2015)
Cognitive impairment 18 years before clinical diagnosis of Alzheimer disease dementia
Kumar B. Rajan et al.
NEUROLOGY (2015)
Apolipoprotein E ε4 Modulates Cognitive Profiles, Hippocampal Volume, and Resting-State Functional Connectivity in Alzheimer's Disease
Xiao Wang et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Amyloid-β Oligomers Relate to Cognitive Decline in Alzheimer's Disease
Wesley Jongbloed et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
A Sensitive Aβ Oligomer Assay Discriminates Alzheimer's and Aged Control Cerebrospinal Fluid
Mary J. Savage et al.
JOURNAL OF NEUROSCIENCE (2014)
The Amyloid-β Oligomer Count in Cerebrospinal Fluid is a Biomarker for Alzheimer's Disease
Lei Wang-Dietrich et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Correlation of Aβ oligomer levels in matched cerebrospinal fluid and serum samples
Takashi Kasai et al.
NEUROSCIENCE LETTERS (2013)
Plasma amyloid-β oligomers level is a biomarker for Alzheimer's disease diagnosis
L. Zhou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Amyloid-β Oligomers in Cerebrospinal Fluid are Associated with Cognitive Decline in Patients with Alzheimer's Disease
Alexander Navarrete Santos et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
High-molecular-weight β-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients
Hiroaki Fukumoto et al.
FASEB JOURNAL (2010)
The common objects memory test (COMT): A simple test with cross-cultural applicability
Daniel Kempler et al.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2010)
A Specific Enzyme-Linked Immunosorbent Assay for Measuring β-Amyloid Protein Oligomers in Human Plasma and Brain Tissue of Patients With Alzheimer Disease
Weiming Xia et al.
ARCHIVES OF NEUROLOGY (2009)
Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction
Jennifer L. Tomic et al.
NEUROBIOLOGY OF DISEASE (2009)
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
Ganesh M. Shankar et al.
NATURE MEDICINE (2008)
Research criteria for the diagnosis of Alzheimers disease: revising the NINCDS-ADRDA criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2007)
Aβ oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease
Pascale N. Lacor et al.
JOURNAL OF NEUROSCIENCE (2007)
Vascular volume and blood-brain barrier permeability measured by dynamic contrast enhanced MRI in hippocampus and cerebellum of patients with MCI and normal controls
Huali Wang et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2006)
Diagnostic utility of neuropsychological performance and quantitative MRI-based measurement in Alzheimer disease
HL Wang et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2004)
Synaptic targeting by Alzheimer's-related amyloid β oligomers
PN Lacor et al.
JOURNAL OF NEUROSCIENCE (2004)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
分享论文
